Park Doctrine Could Be Limited By Upcoming Cases, Attorney Argues
Executive Summary
As penalties increase under responsible corporate officer doctrine, attorney Allison Burroughs, a partner at Nutter McClennen & Fish, says to expect increased scrutiny.
You may also be interested in...
FDA Prosecution Criteria For “Responsible” Execs Includes Seriousness, Obviousness Of Violations
Almost a year after signaling its intent to target more individual executives with misdemeanor prosecutions when their companies have broken the law, FDA has published its criteria for pursuing such cases.
Still Guilty: Three Former Purdue Execs Lose Fight To Overturn Their Exclusion From Gov't Programs
"As with plaintiffs' repeated attempts to characterize themselves as innocent third parties to Purdue's misbranding, the court finds plaintiffs' arguments with respect to financial loss reflective of a fundamental misconception of their own plea agreements," the ruling states.
Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First
FDA appears likely to target flagrant off-label promotion in its first cases under new procedures for using the Park Doctrine and strict liability statutes to prosecute corporate executives and others.